These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. European multicentre evaluation of the analytical performance of the Abbott AxSYM Abused Drugs Assays. von Meyer L, Hänseler E, Lardet G, Scholer A, Sieghart W. Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):133-40. PubMed ID: 9056758 [Abstract] [Full Text] [Related]
29. Abbott phencyclidine and barbiturates abused drug assays: evaluation and comparison of ADx FPIA, TDx FPIA, EMIT, and GC/MS methods. Caplan YH, Levine B. J Anal Toxicol; 1989 Feb; 13(5):289-92. PubMed ID: 2693834 [Abstract] [Full Text] [Related]
30. Comparison of capillary electrophoresis-based immunoassay with fluorescence polarization immunoassay for the immunodetermination of methamphetamine using various methamphetamine antibodies. Choi J, Kim C, Choi MJ. Electrophoresis; 1998 Nov; 19(16-17):2950-5. PubMed ID: 9870395 [Abstract] [Full Text] [Related]
31. Drug screening in "normal" controls. Swerdlow NR, Geyer MA, Perry W, Cadenhead K, Braff DL. Biol Psychiatry; 1995 Jul 15; 38(2):123-4. PubMed ID: 7578645 [No Abstract] [Full Text] [Related]
32. Detection of drug abuse by health professionals. Meeker JE, Mount AM, Ross W. J Healthc Prot Manage; 2003 Jul 15; 19(1):73-81. PubMed ID: 12629790 [Abstract] [Full Text] [Related]
33. An evaluation of the TRI Dipstick test for the detection of drugs of abuse in urine. Wallace JA, Blum K. Subst Alcohol Actions Misuse; 1982 Jul 15; 3(1-2):129-32. PubMed ID: 6753193 [No Abstract] [Full Text] [Related]